Privi Speciality Chemicals Limited · NSE:PRIVISCL
Privi Speciality Chemicals — Investor Presentation (August 2021)
34 slides from Privi Speciality Chemicals's investor presentation, Aug 25, 2021
Slide 1: Exchange intimation cover letter
August 25, 2021 The Manager (CRD) The BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai- 400 001 The Manager — Listing Department National Stock Exchange of India Ltd Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (East) Mumbai - 400 051 Scrip Code: 530117 Symbol
Slide 2: Privi Speciality Chemicals Ltd Investor Presentation
Privi Speciality Chemicals Ltd Presentation August 2021 Investor Presentation 1 August 2021
Slide 3: Content
Content 01 Company Overview 02 Industry Overview 03 Business Overview 04 Infrastructure Overview 05 Financial Overview Investor Presentation 2 August 2021
Slide 4: About Privi
About Privi Revenue (Rs lakhs) and EBITDA margin Revenue EBITDA% Fast growing manufacturer of Aroma Chemicals (specialty chemicals 1,60,000 20.99% 22.00% forming key ingredients in formulation of fragrances) 19.33% 1,40,000 17.39% 1,35,047 1,29,652 Global leaders in key products we manufacture 17.00
Slide 5: Subsidiaries
Subsidiaries PRIVI BIOTECHNOLOGIES PVT LTD • Fully equipped biotechnology center at Nerul, Navi Mumbai with highly skilled and qualified operational team of 30 odd scientists • Research areas in biotechnology including fermentation, enzymology, biotransformation, and chromatography. • Technology col
Slide 6: Board of Directors
Board of Directors Mr. Mahesh Babani Mr. D. B. Rao Mr. Rajesh Budhrani Mr. Dwarko Khilnani Mr. P. R. Barpande Mr. Anurag Surana Mrs. Anuradha Thakur Chairman & Executive Independent Independent Independent Independent Independent Managing Director Director Director Director Director Director Directo
Slide 7: Executive Team
Executive Team MAHESH BABANI CHAIRMAN & MANAGING DIRECTOR D. B. RAO EXECUTIVE DIRECTOR R S RAJAN PRESIDENT HARISH RAHEJA G. MITTAL NARAYAN IYER S. B.PATHARE J. MARATHE D. RAGHAVA SANJEEV PATIL RAM SURVE VP- BUSINESS Sr. VP-COMMERCIAL CHIEF FINANCIAL Exec. VP – Sr. VP – Sr. VP - OPERATIONS Sr. VP - S
Slide 8: Key Milestones
Key Milestones Longer term Induction of contracts – full time CEO, Givaudan, P&G, paving way to Henkel Name change Amalgamation professionally to Privi and name managed Commenced Organics India change to Privi company Private Equity production at Ltd, subsidiary Speciality investment by Unit-VI Guja
Slide 9: Content
Content 01 Company Overview 02 Industry Overview 03 Business Overview 04 Infrastructure Overview 05 Financial Overview Investor Presentation 8 August 2021
Slide 10: Industry Overview
Industry Overview • Privi operates in Aroma chemicals (Fragrance Ingredients) market which is a part Flavour and Fragrance (F&F) Industry • Global F&F market size is about USD 30.4 Bn (53%) Flavours (47%) • Fragrance accounts for about USD 16.1 Bn (53%) of the total F&F market • Within Fragrance, Ar
Slide 11: Industry Overview
Industry Overview • Terpenes & Terpenoids possess effective medicinal properties, such as antiseptic, anti-carcinogen, and anti-microbial properties Aroma Chemicals Segments • Musk chemicals find scope in different applications, such as soap, Others (16%) detergents, cosmetics and personal care, foo
Slide 12: Aroma Chemicals Value Chain
Aroma Chemicals Value Chain Raw Material Source Building Blocks Aroma Chemicals Market Segmentation Formulators FMCG Naphthalene Value % Volume % Perfume Floral Cresol Soft Floral After Shave Catechol Petrochemical Styrene Floral oriental Fine Fragrances Isobutene 34% 48% Orienta
Slide 13: Content
Content 01 Company Overview 02 Industry Overview 03 Business Overview 04 Infrastructure Overview 05 Financial Overview Investor Presentation 12 August 2021
Slide 14: Product Segment
Product Segment PINENE PHENOL CITRAL SPECIALITY • Dihydromyrcenol • Ortho Tertiary Butyl • Cyclocitral • Damascones • Amber Fleur Cyclo Hexyl Acetate • Citronellal • Sandal Products • Pine Oil • Para Tertiary Butyl Cyclo • Citronellol • Ionones • Terpineol Hexyl Acetate • Citronellyl Nitrile • Nimbe
Slide 15: Sales Geography
Sales Geography Export to 30+ Countries Global Delivery Capabilities Stocking Points India Rotterdam (Netherland) Russia New Jersey (USA) UK Netherland Distribution Points Germany Singapore (Asia Pacific) France Switzerland Turkey Shanghai (Asia Pacific) USA Spain Italy Greece Israel China Japa
Slide 16: Key Strengths
Key Strengths Leadership position in the world market for products like- DHMOL, Amber fleur, Terpineol, Pine Oil. Constant benchmarking of operations in Ideal balance of entrepreneurship terms of energy costs and processing and professional management Scale of operation yields Management Team Operat
Slide 17: Sustainability
Sustainability We provide assistance in the construction and repair of toilets in the surrounding areas & works to create awareness about hygiene We contribute towards the skill development of the people in We believe in remaining one step the surrounding villages so that they can obtain employment
Slide 18: Sustainability
Sustainability 2019-21 2018-19 Progressing 2017-18 towards Zero Self reliance in Liquid 2015-17 Power Discharge Working for 2013-15 Zero effluent Water Recycle water discharge 2011-13 & Reuse across Implemented all units 2008-11 Green Process Water Recycle (leading to Till 2008 & Reuse at U2 reducti
Slide 19: Corporate Social Responsibility
Corporate Social Responsibility Education Healthcare Environment • Facilitating education of school • Health check-up camps, blood • Plantation of trees. children from underprivileged donation camps and cataract • Cleaning drives and sanitization families. operation camps. practices. • Distribution
Slide 20: Content
Content 01 Company Overview 02 Industry Overview 03 Business Overview 04 Infrastructure Overview 05 Financial Overview Investor Presentation 19 August 2021
Slide 21: Infrastructure
Infrastructure OPTIMUM PRODUCTION CAPACITY - 37,000 MTPA CST PROCESSING CAPACITY - 36,000 MTPA TOTAL PLANT AREA - 226,500 Sq mt TOTAL REACTION CAPACITY - 500 KL TOTAL DISTILLATION CAPACITY - 900 KL/Day BLENDING CAPACITY - 500 KL STEAM GENERATION - 78 Tons/Hour CONNECTED POWER - 13,40
Slide 22: Unit 1 and 3
Unit 1 and 3 Unit 1 - Amber Fleur Unit 3 - Pine oil and Terpineol Investor Presentation 21 August 2021
Slide 23: Unit 2
Unit 2 Unit 2 is the largest unit of Privi. Products like DHMOL, Citral based and speciality products are manufactured at this site. It also houses the Crude sulphated turpentine and Gum turpentine processing facility (Single largest refinery globally). Investor Presentation August 2021
Slide 24: Unit 10
Unit 10 Unit 10 is the newly constructed Supply chain excellence centre. Raw materials and Finished goods are stored here. Total Capacity of 7400 KL RM storage = 1450 pallets = 5800 drums equivalent FG storage = 2200 pallets = 8800 drums equivalent Investor Presentation 23 August 2021
Slide 25: Ongoing Projects
Ongoing Projects GALAXMUSK CAMPHOR PRIONYL Capacity -4800 TPA Capacity – 4800 TPA Capacity – 120 TPA Start - April 2022 Start – April 2022 Start – April 2022 Location - Jhagadia, Gujarat Location - Mahad, Maharashtra Location - Mahad, Maharashtra Investor Presentation 24 August 2021
Slide 26: Content
Content 01 Company Overview 02 Industry Overview 03 Business Overview 04 Infrastructure Overview 05 Financial Overview Investor Presentation 25 August 2021
Slide 27: Financial Highlight
Financial Highlight Revenue EBITDA PBT EBITDA EBITDA% PBT PBT% 30,000 21.0% 25,000 25.0% 14.3% 28,351 19.3% 12.2% 25,000 17.4% 20,000 20.0% 11.5% 25,063 20,000 19,263 Rs Lakhs Rs lakhs Rs lakhs 15,000 15.0% 19,078 15,822 1,35,047 15,000 1,29,652 12,609 1,09,677 10,000 10.0% 10,000 5,000 5,000 5.0% 0
Slide 28: Financial Highlight
Financial Highlight Figures in Rs lakhs Figures in Tons Sales breakup - Segment wise Actual Volume breakup - Segment wise Actual 9,806 990 8% 1,636 3% 17,099 6% 13% 3,996 Pinene 14% Pinene 8,916 Phenol Phenol 7% 1,27,656 29,337 Citral Citral 91,835 Speciality Speciality 22,715 72% 77% Investor Prese
Slide 29: Financial Highlight
Financial Highlight Net Debt/Equity Net Debt/EBITDA 0.88 2.19 2.06 0.71 0.68 1.46 FY19 (A) FY 20 (A) FY 21 (A) FY19 (A) FY 20 (A) FY 21 (A) ROE ROCE Cash Conversion Days 23.96% 149 16.18% 16.10% 117 118 20.34% 16.47% Days 14.33% FY19 (A) FY 20 (A) FY 21 (A) FY19 (A) FY 20 (A) FY 21 (A) Investor Pres
Slide 30: Income Statement
Income Statement Figures in Rs lakhs Description FY 18-19 FY 19-20 FY 20-21 Revenue 1,09,117 1,32,411 1,27,656 Other income 560 2,636 1,996 Total Income 1,09,677 1,35,047 1,29,652 Cost of goods sold 66,161 80,313 75,109 Employee benefits expense 5,610 6,503 6,987 Finance cost 2,328 3,411 2,141 Depre
Slide 31: Balance Sheet
Balance Sheet Figures in Rs lakhs Description FY 18-19 FY 19-20 FY 20-21 Description FY 18-19 FY 19-20 FY 20-21 ASSETS EQUITY AND LIABILITIES Non-current assets EQUITY Property, plant and equipment 37,374 55,929 56,021 Equity share capital 1 3,906 3,906 Capital Work in Progress 9,378 3,027 17,445 Ot
Slide 32: Cashflow Statement
Cashflow Statement Figures in Rs lakhs Description FY 18-19 FY 19-20 FY 20-21 Profit before tax 12,609 19,263 15,822 Depreciation and amortisation 4,141 5,677 7,100 Interest expense 2,328 3,334 2,093 Other non-cash, non-operating items 303 -1,127 1,317 Taxes paid -2,526 -6,655 -3,968 Cash flow befor
Slide 33: Capital Market
Capital Market PSCL BSE Sensex Dividend Percentage 1,800 60,000 1,600 25% 50,000 1,400 PSCL Share Price 1,200 40,000 20% BSE Sensex 1,000 30,000 15% 15% 800 600 20,000 10% 400 10,000 200 0 0 Dec-20 Jul-21 Sep-20 Oct-20 Nov-20 Jan-21 Feb-21 Mar-21 Apr-21 May-21 Jun-21 Aug-21 * Aug’21 data till 20th A
Slide 34: Disclaimer
DISCLAIMER “This Presentation, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expressions or variati
Privi Speciality Chemicals — Investor Presentation (August 2021) on 6ix